Schedule of effects of the restatement |
The
effects of the restatements to the amounts presented in the consolidated statement of financial position and the consolidated statement
of cash flow are summarised as below.
Schedule
of effects of the restatement
| |
| | | |
| | | |
| |
|
|
|
| | |
| | |
| |
As previously | | |
Adjustments | | |
As | |
| |
stated | | |
(a) | | |
(b) |
|
|
(c) | | |
restated | |
| |
| | |
| | |
|
|
|
|
| | |
| |
Consolidated statement of financial position as at 30 March 2024 | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Non-Current Assets | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Intangible assets | |
| 143,185 | | |
| - | | |
| 694,618 |
|
|
|
- | | |
| 837,803 | |
Other investments | |
| - | | |
| 1,492,955 | | |
| - |
|
|
|
(1,492,955 | ) | |
| - | |
Investment in associates | |
| 5,101 | | |
| - | | |
| - |
|
|
|
1,501,543 | | |
| 1,506,644 | |
| |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Current Assets | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Other receivables, deposits and prepayments | |
| 1,727,828 | | |
| (1,492,955 | ) | |
| - |
|
|
|
- | | |
| 234,873 | |
| |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Current Liabilities | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Other payables and accruals | |
| 400,368 | | |
| - | | |
| 555,695 |
|
|
|
- | | |
| 956,063 | |
Amount due to directors | |
| 3,471,788 | | |
| - | | |
| 138,923 |
|
|
|
- | | |
| 3,610,711 | |
| |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Capital and Reserves | |
| | | |
| | | |
| | | |
| | | |
| | |
Accumulated losses | |
| (8,660,408 | ) | |
| - | | |
| - | | |
| 8,742 | | |
| (8,651,666 | ) |
Foreign translation reserve | |
| (245,557 | ) | |
| - | | |
| - | | |
| (154 | ) | |
| (245,711 | ) |
Consolidated statement of profit or loss and other comprehensive income for the
financial year ended 30 March 2024 | |
| | | |
| | | |
| | | |
| | | |
| | |
Share result of associate | |
| (5,321 | ) | |
| - | | |
| - | | |
| 8,742 | | |
| 3,421 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Other comprehensive loss, net of income tax | |
| | | |
| | | |
| | | |
| | | |
| | |
Foreign currency translation, representing other comprehensive loss for the
financial year | |
| (121,144 | ) | |
| - | | |
| - | | |
| (154 | ) | |
| (121,298 | ) |
| |
stated | | |
(a) | | |
(b) | | |
(c) | | |
restated | |
| |
As previously | | |
Adjustments | | |
As | |
| |
stated | | |
(a) | | |
(b) | | |
(c) | | |
restated | |
| |
| | |
| | |
| | |
| | |
| |
Consolidated statement of cash flows for the financial year ended 31 March 2024 | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Cash flows used in operating activities | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Loss before tax | |
| (2,407,317 | ) | |
| - | | |
| - | | |
| 8,742 | | |
| (2,398,575 | ) |
Adjustments for: | |
| | | |
| | | |
| | | |
| | | |
| | |
Share of results of associates | |
| 5,321 | | |
| - | | |
| - | | |
| (8,742 | ) | |
| (3,421 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Change in working capital | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Decrease in other receivables, deposits and prepayments | |
| (1,467,360 | ) | |
| 1,492,955 | | |
| - |
|
|
|
- | | |
| 25,595 | |
| |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Cash flows used in investing activities | |
| | | |
| | | |
| |
|
|
|
| | |
| | |
Investment in unquoted shares | |
| - | | |
| (1,492,955 | ) | |
| - |
|
|
|
1,492,955 | | |
| - | |
Investment in
an associate | |
| - | | |
| - | | |
| - |
|
|
|
(1,492,955 | ) | |
| (1,492,955 | ) |
|